![John Reynders](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Reynders
Directeur/Membre du Conseil chez
CERTARA, INC.
Fortune : 154 032 $ au 31/05/2026
Profil
John V.
W.
Reynders is the founder of Latent Strategies LLC.
Current jobs include Director at Rare-X and Independent Director at Certara, Inc. starting in 2024.
Former jobs include Director & Program Manager at Los Alamos National Laboratory, VP-Pharmaceutical Research & Development at Johnson & Johnson, Information Officer-Discovery Division at Eli Lilly & Co., Principal at Sun Microsystems, Inc., Vice President-R&D Bioinformatics at Alexion Pharmaceuticals, Inc. from 2014 to 2020, Vice President-Information Systems at Celera Group, Chief Information Officer at ModernaTX, Inc., Chief Information Officer at Moderna, Inc., Chief Data Sciences Officer at Neumora Therapeutics, Inc., and Vice President-Research & Development at AstraZeneca, Inc. Education includes a doctorate from Princeton University, an undergraduate degree from Rensselaer Polytechnic Institute, and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERTARA, INC. 0,02% | 14/05/2026 | 26 466 ( 0,02% ) | 154 032 $ | 31/05/2026 |
Postes actifs de John Reynders
| Sociétés | Poste | Début |
|---|---|---|
| CERTARA, INC. | Directeur/Membre du Conseil | 15/10/2024 |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Operates as a patient data processing platform | Directeur/Membre du Conseil | - |
Anciens postes connus de John Reynders
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2020 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Directeur Technique/Scientifique/R&D | - |
| MODERNA, INC. | Directeur Technique/Scientifique/R&D | - |
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Los Alamos National Laboratory
 Los Alamos National Laboratory Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development for National Nuclear Security Administration | Directeur/Membre du Conseil | - |
Formation de John Reynders
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Sun Microsystems, Inc.
 Sun Microsystems, Inc. SemiconductorsElectronic Technology Develops computer and storage systems, high-speed microprocessors and software solutions for computer networking | Electronic Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Los Alamos National Laboratory
Los Alamos National Laboratory Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development for National Nuclear Security Administration | Commercial Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Certara, Inc.
 Certara, Inc. Packaged SoftwareTechnology Services Develops bio simulation software and technology to transform traditional drug discovery and development | Technology Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Rare-X
Rare-X Packaged SoftwareTechnology Services Operates as a patient data processing platform | Technology Services |
